"BoneBank" is intended to make it possible in future to obtain and utilize bone marrow stem cells from routine fracture-related operations. The German-Danish BoneBank project to establish a biobank for bone marrow stem cells with a total volume of 2.3 million euros will be funded from September 2015 by the Interreg Deutschland-Danmark funding programme.
The declared goal is the extraction of bone marrow stem cells as part of routine operations in the German and Danish trauma centres of Lübeck and Odense. Building on this, the establishment of a cross-border biobank for bone marrow stem cells will be promoted. "The BoneBank project paves the way for new stem cell therapies with versatile applications, e.g. in cancer therapy or bone healing. In addition, BoneBank offers an important innovation platform for new medical products and therapies in regenerative medicine," said Prof. Dr. Arndt Peter Schulz, senior physician at the Clinic for Orthopaedics and Trauma Surgery at the UKSH and member of the board of the Life Science Nord e.V..

Lead partner of the consortium is the University Hospital Schleswig-Holstein (UKSH) in Lübeck. Together with the project partners Universitätsklinikum Odense, Stryker Trauma GmbH, soventec GmbH and Life Science Nord Management GmbH, a comprehensive concept was developed last year. The project development was supported by the Kiel-based company DSN Connecting Knowledge.

"With BoneBank, the consortium is taking an innovative approach to making stem cells even more usable for research and therapy. At the same time, the project strengthens cooperation between German and Danish companies, clinics and research institutions," says Dr. Hinrich Habeck, Managing Director of Life Science Nord Management GmbH.

soventec will contribute concepts and implementation for the networking of the biobanks and the subsequent connection of the donation centres.

https://www.bonebank.eu

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline